逍遥散治疗慢性乙肝38例疗效观察

Xiaoyaosan in the Treatment of Chronic Hepatitis B:Clinical Observation of 38 Cases

目的:观察逍遥散治疗慢性乙型肝炎的临床疗效与安全性。方法:将符合纳入标准的76例慢性乙肝患者随机分为对照组和治疗组各38例。对照组采用常规基础治疗;治疗组在对照组基础上予逍遥散口服,疗程30天,观察治疗前后症状及肝功能改善情况。结果:治疗组临床症状及肝功能明显改善,总有效率为97.4%,与对照组比较有显著性差异(P<0.05),未见由药物引起的不良反应。结论:逍遥散在改善症状及肝功能方面疗效显著。

Objective：To observe the clinical efficacy and safety in the treatment of chronic hepatitis B of Xiaoyaosan.Methods：76 patients with chronic hepatitis B were randomly divided into two groups： control group with 38 cases was treated with conventional basic therapy;treatment group of 38 cases was on the basis of control group and Xiaoyaosan for oral.The treatment was for 30 days.To observe Improvement of symptoms and liver function before and after treatment.Results：The clinical symptoms and liver function improved significantly,with a total effective rate of 97.4%.Compared with the control group there was a significant difference（P0.05）,and no adverse reactions were caused by drugs.Conclusion：Xiaoyaosan has a better efficacy on improving symptoms and liver function.It obviously enhances the clinical efficacy,which has a good prospect for application.